C

Coya Therapeutics Inc
NASDAQ:COYA

Watchlist Manager
Coya Therapeutics Inc
NASDAQ:COYA
Watchlist
Price: 6.68 USD 9.87% Market Closed
Market Cap: 111.6m USD
Have any thoughts about
Coya Therapeutics Inc?
Write Note

Relative Value

The Relative Value of one COYA stock under the Base Case scenario is 4.84 USD. Compared to the current market price of 6.68 USD, Coya Therapeutics Inc is Overvalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

COYA Relative Value
Base Case
4.84 USD
Overvaluation 28%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
24
vs Industry
35
Median 3Y
0
Median 5Y
0
Industry
7.7
Forward
20.3
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-5.6
Industry
22.7
Forward
-4.5
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-6.5
Industry
21.6
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-6.2
Industry
25.2
vs History
28
vs Industry
30
Median 3Y
2.9
Median 5Y
2.9
Industry
2.5
vs History
24
vs Industry
37
Median 3Y
0
Median 5Y
0
Industry
7.7
Forward
13
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-5.4
Industry
4.2
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-5.4
Industry
4.1
Forward
-3
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-6.6
Industry
5.7
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-6.6
Industry
3.6
vs History
31
vs Industry
20
Median 3Y
38
Median 5Y
38
Industry
4.6

Multiples Across Competitors

COYA Competitors Multiples
Coya Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Coya Therapeutics Inc
NASDAQ:COYA
101.7m USD 10.6 -10.1 -6.4 -6.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
US
C
Coya Therapeutics Inc
NASDAQ:COYA
Average P/E: 208
Negative Multiple: -10.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
US
C
Coya Therapeutics Inc
NASDAQ:COYA
Average EV/EBITDA: 17.2
Negative Multiple: -6.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
US
C
Coya Therapeutics Inc
NASDAQ:COYA
Average EV/EBIT: 22.5
Negative Multiple: -6.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top